Voxel S.A. (VOX) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Voxel S.A. (VOX) has a cash flow conversion efficiency ratio of 0.072x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł32.28 Million ≈ $8.88 Million USD) by net assets (zł448.06 Million ≈ $123.31 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see VOX company net worth for the company's overall valuation and market capitalisation.
Voxel S.A. - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Voxel S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.
Voxel S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Voxel S.A. ranked by their cash flow conversion efficiency. Explore Voxel S.A. (VOX) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Shouxiangu Pharm Co
SHG:603896
|
0.009x |
|
Huchems
KO:069260
|
0.030x |
|
SoluM Co Ltd
KO:248070
|
-0.048x |
|
Star Gas Partners LP
NYSE:SGU
|
0.304x |
|
Attica Holdings S.A.
AT:ATTICA
|
0.023x |
|
Benitec Biopharma Ltd ADR
NASDAQ:BNTC
|
-0.020x |
|
Xingyuan Environment Technology Co Ltd
SHE:300266
|
0.082x |
|
Brainsway Ltd
TA:BWAY
|
0.020x |
Annual Cash Flow Conversion Efficiency for Voxel S.A. (2010–2025)
The table below shows the annual cash flow conversion efficiency of Voxel S.A. from 2010 to 2025. View current stock price of Voxel S.A. for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | zł415.63 Million ≈ $114.39 Million |
zł116.69 Million ≈ $32.11 Million |
0.281x | -15.86% |
| 2024-12-31 | zł366.64 Million ≈ $100.90 Million |
zł122.34 Million ≈ $33.67 Million |
0.334x | -16.80% |
| 2023-12-31 | zł295.41 Million ≈ $81.30 Million |
zł118.47 Million ≈ $32.60 Million |
0.401x | +1.68% |
| 2022-12-31 | zł243.91 Million ≈ $67.13 Million |
zł96.20 Million ≈ $26.48 Million |
0.394x | -14.50% |
| 2021-12-31 | zł230.53 Million ≈ $63.44 Million |
zł106.34 Million ≈ $29.27 Million |
0.461x | +40.71% |
| 2020-12-31 | zł181.17 Million ≈ $49.86 Million |
zł59.39 Million ≈ $16.35 Million |
0.328x | +3.74% |
| 2019-12-31 | zł155.77 Million ≈ $42.87 Million |
zł49.22 Million ≈ $13.55 Million |
0.316x | +49.59% |
| 2018-12-31 | zł143.25 Million ≈ $39.43 Million |
zł30.26 Million ≈ $8.33 Million |
0.211x | -21.97% |
| 2017-12-31 | zł130.46 Million ≈ $35.90 Million |
zł35.32 Million ≈ $9.72 Million |
0.271x | +40.21% |
| 2016-12-31 | zł116.38 Million ≈ $32.03 Million |
zł22.47 Million ≈ $6.18 Million |
0.193x | -36.60% |
| 2015-12-31 | zł111.15 Million ≈ $30.59 Million |
zł33.85 Million ≈ $9.32 Million |
0.305x | +51.93% |
| 2014-12-31 | zł103.47 Million ≈ $28.48 Million |
zł20.74 Million ≈ $5.71 Million |
0.200x | +335.76% |
| 2013-12-31 | zł108.89 Million ≈ $29.97 Million |
zł5.01 Million ≈ $1.38 Million |
0.046x | -5.05% |
| 2012-12-31 | zł82.64 Million ≈ $22.74 Million |
zł4.00 Million ≈ $1.10 Million |
0.048x | -23.96% |
| 2011-12-31 | zł83.39 Million ≈ $22.95 Million |
zł5.31 Million ≈ $1.46 Million |
0.064x | -88.43% |
| 2010-12-31 | zł72.36 Million ≈ $19.92 Million |
zł39.85 Million ≈ $10.97 Million |
0.551x | -- |
About Voxel S.A.
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.